Today: 30 April 2026
Browse Category

NYSE:GDOG 23 November 2025 - 26 November 2025

Dogecoin Today, November 26, 2025: Price Holds Near $0.15 as New Wall Street ETFs GDOG and BWOW Struggle to Ignite Demand

Dogecoin Today, November 26, 2025: Price Holds Near $0.15 as New Wall Street ETFs GDOG and BWOW Struggle to Ignite Demand

Dogecoin traded near $0.15 on November 26, up less than 1% from the previous day and over 60% lower than a year ago. Grayscale’s GDOG, the first U.S. spot Dogecoin ETF, launched November 24 with just $1.4 million in first-day volume, far below projections. Bitwise’s BWOW Dogecoin ETF began trading today on the NYSE.
26 November 2025
···

Stock Market Today

  • Needham & Company Raises Alphabet (GOOGL) Price Target to $450, Citing Strong Upside
    April 30, 2026, 8:48 AM EDT. Needham & Company LLC upgraded Alphabet Inc. (NASDAQ: GOOGL) stock target from $400 to $450, reflecting a potential 28.6% gain. The firm reiterates a "buy" rating on the tech giant. Other analysts, including Robert W. Baird and Wedbush, also raised their price targets, indicating broad bullish sentiment. Alphabet's shares opened at $349.94 with a $4.23 trillion market cap. The company posted impressive earnings of $5.11 per share for Q1, beating estimates by $2.47. Revenue topped $109.9 billion, higher than expected. Alphabet maintains a solid return on equity of 35.01% and a net margin of nearly 33%. Insider John L. Hennessy's recent sale of shares was noted but does not appear to impact overall positive analyst outlooks.

Latest article

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

30 April 2026
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market had bottomed and highlighted progress in data-center chips. Fiscal Q2 revenue fell 3% to $10.6 billion, with handset revenue down 13% but automotive up 38%. The Q3 forecast missed Wall Street estimates. Qualcomm expects chip sales to Chinese handset makers to recover after Q3.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Go toTop